Tanjala S Purnell1,2,3,4, Xun Luo1, Lisa A Cooper2,3,4,5, Allan B Massie1,2, Lauren M Kucirka1,2, Macey L Henderson1, Elisa J Gordon6, Deidra C Crews4,7, L Ebony Boulware8, Dorry L Segev1,2. 1. Division of Transplantation, Department of Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland. 2. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 3. Department of Health Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 4. Johns Hopkins Center for Health Equity, Johns Hopkins University, Baltimore, Maryland. 5. Division of General Internal Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland. 6. Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois. 7. Division of Nephrology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland. 8. Division of General Internal Medicine, Duke University School of Medicine, Durham, North Carolina.
Abstract
Importance: Over the past 2 decades, there has been increased attention and effort to reduce disparities in live donor kidney transplantation (LDKT) for black, Hispanic, and Asian patients with end-stage kidney disease. The goal of this study was to investigate whether these efforts have been successful. Objective: To estimate changes over time in racial/ethnic disparities in LDKT in the United States, accounting for differences in death and deceased donor kidney transplantation. Design, Setting, and Participants: A secondary analysis of a prospectively maintained cohort study conducted in the United States of 453 162 adult first-time kidney transplantation candidates included in the Scientific Registry of Transplant Recipients between January 1, 1995, and December 31, 2014, with follow-up through December 31, 2016. Exposures: Race/ethnicity. Main Outcomes and Measures: The primary study outcome was time to LDKT. Multivariable Cox proportional hazards and competing risk models were constructed to assess changes in racial/ethnic disparities in LDKT among adults on the deceased donor kidney transplantation waiting list and interaction terms were used to test the statistical significance of temporal changes in racial/ethnic differences in receipt of LDKT. The adjusted subhazard ratios are estimates derived from the multivariable competing risk models. Data were categorized into 5-year increments (1995-1999, 2000-2004, 2005-2009, 2010-2014) to allow for an adequate sample size in each analytical cell. Results: Among 453 162 adult kidney transplantation candidates (mean [SD] age, 50.9 [13.1] years; 39% were women; 48% were white; 30%, black; 16%, Hispanic; and 6%, Asian), 59 516 (13.1%) received LDKT. Overall, there were 39 509 LDKTs among white patients, 8926 among black patients, 8357 among Hispanic patients, and 2724 among Asian patients. In 1995, the cumulative incidence of LDKT at 2 years after appearing on the waiting list was 7.0% among white patients, 3.4% among black patients, 6.8% among Hispanic patients, and 5.1% among Asian patients. In 2014, the cumulative incidence of LDKT was 11.4% among white patients, 2.9% among black patients, 5.9% among Hispanic patients, and 5.6% among Asian patients. From 1995-1999 to 2010-2014, racial/ethnic disparities in the receipt of LDKT increased (P < .001 for all statistical interaction terms in adjusted models comparing white patients vs black, Hispanic, and Asian patients). In 1995-1999, compared with receipt of LDKT among white patients, the adjusted subhazard ratio was 0.45 (95% CI, 0.42-0.48) among black patients, 0.83 (95% CI, 0.77-0.88) among Hispanic patients, and 0.56 (95% CI, 0.50-0.63) among Asian patients. In 2010-2014, compared with receipt of LDKT among white patients, the adjusted subhazard ratio was 0.27 (95% CI, 0.26-0.28) among black patients, 0.52 (95% CI, 0.50-0.54) among Hispanic patients, and 0.42 (95% CI, 0.39-0.45) among Asian patients. Conclusions and Relevance: Among adult first-time kidney transplantation candidates in the United States who were added to the deceased donor kidney transplantation waiting list between 1995 and 2014, disparities in the receipt of live donor kidney transplantation increased from 1995-1999 to 2010-2014. These findings suggest that national strategies for addressing disparities in receipt of live donor kidney transplantation should be revisited.
Importance: Over the past 2 decades, there has been increased attention and effort to reduce disparities in live donor kidney transplantation (LDKT) for black, Hispanic, and Asian patients with end-stage kidney disease. The goal of this study was to investigate whether these efforts have been successful. Objective: To estimate changes over time in racial/ethnic disparities in LDKT in the United States, accounting for differences in death and deceased donor kidney transplantation. Design, Setting, and Participants: A secondary analysis of a prospectively maintained cohort study conducted in the United States of 453 162 adult first-time kidney transplantation candidates included in the Scientific Registry of Transplant Recipients between January 1, 1995, and December 31, 2014, with follow-up through December 31, 2016. Exposures: Race/ethnicity. Main Outcomes and Measures: The primary study outcome was time to LDKT. Multivariable Cox proportional hazards and competing risk models were constructed to assess changes in racial/ethnic disparities in LDKT among adults on the deceased donor kidney transplantation waiting list and interaction terms were used to test the statistical significance of temporal changes in racial/ethnic differences in receipt of LDKT. The adjusted subhazard ratios are estimates derived from the multivariable competing risk models. Data were categorized into 5-year increments (1995-1999, 2000-2004, 2005-2009, 2010-2014) to allow for an adequate sample size in each analytical cell. Results: Among 453 162 adult kidney transplantation candidates (mean [SD] age, 50.9 [13.1] years; 39% were women; 48% were white; 30%, black; 16%, Hispanic; and 6%, Asian), 59 516 (13.1%) received LDKT. Overall, there were 39 509 LDKTs among white patients, 8926 among black patients, 8357 among Hispanic patients, and 2724 among Asian patients. In 1995, the cumulative incidence of LDKT at 2 years after appearing on the waiting list was 7.0% among white patients, 3.4% among black patients, 6.8% among Hispanic patients, and 5.1% among Asian patients. In 2014, the cumulative incidence of LDKT was 11.4% among white patients, 2.9% among black patients, 5.9% among Hispanic patients, and 5.6% among Asian patients. From 1995-1999 to 2010-2014, racial/ethnic disparities in the receipt of LDKT increased (P < .001 for all statistical interaction terms in adjusted models comparing white patients vs black, Hispanic, and Asian patients). In 1995-1999, compared with receipt of LDKT among white patients, the adjusted subhazard ratio was 0.45 (95% CI, 0.42-0.48) among black patients, 0.83 (95% CI, 0.77-0.88) among Hispanic patients, and 0.56 (95% CI, 0.50-0.63) among Asian patients. In 2010-2014, compared with receipt of LDKT among white patients, the adjusted subhazard ratio was 0.27 (95% CI, 0.26-0.28) among black patients, 0.52 (95% CI, 0.50-0.54) among Hispanic patients, and 0.42 (95% CI, 0.39-0.45) among Asian patients. Conclusions and Relevance: Among adult first-time kidney transplantation candidates in the United States who were added to the deceased donor kidney transplantation waiting list between 1995 and 2014, disparities in the receipt of live donor kidney transplantation increased from 1995-1999 to 2010-2014. These findings suggest that national strategies for addressing disparities in receipt of live donor kidney transplantation should be revisited.
Authors: V B Ashby; F K Port; R A Wolfe; J J Wynn; W W Williams; J P Roberts; A B Leichtman Journal: Am J Transplant Date: 2011-06-14 Impact factor: 8.086
Authors: L Ebony Boulware; Lucy A Meoni; Nancy E Fink; Rulan S Parekh; W H Linda Kao; Michael J Klag; Neil R Powe Journal: Am J Transplant Date: 2005-06 Impact factor: 8.086
Authors: Erin C Hall; Allan B Massie; Nathan T James; Jacqueline M Garonzik Wang; Robert A Montgomery; Jonathan C Berger; Dorry L Segev Journal: Am J Kidney Dis Date: 2011-07-29 Impact factor: 8.860
Authors: L Ebony Boulware; Felicia Hill-Briggs; Edward S Kraus; J Keith Melancon; Brenda Falcone; Patti L Ephraim; Bernard G Jaar; Luis Gimenez; Michael Choi; Mikiko Senga; Maria Kolotos; LaPricia Lewis-Boyer; Courtney Cook; Laney Light; Nicole DePasquale; Todd Noletto; Neil R Powe Journal: Am J Kidney Dis Date: 2012-10-22 Impact factor: 8.860
Authors: Patti L Ephraim; Neil R Powe; Hamid Rabb; Jessica Ameling; Priscilla Auguste; LaPricia Lewis-Boyer; Raquel C Greer; Deidra C Crews; Tanjala S Purnell; Bernard G Jaar; Nicole DePasquale; L Ebony Boulware Journal: BMC Nephrol Date: 2012-10-12 Impact factor: 2.388
Authors: Christopher J Zimmermann; Nathan D Baggett; Lauren J Taylor; Anne Buffington; Joseph Scalea; Norman Fost; Kenneth D Croes; Joshua D Mezrich; Margaret L Schwarze Journal: Am J Transplant Date: 2019-03-14 Impact factor: 8.086
Authors: Karly A Murphy; John W Jackson; Tanjala S Purnell; Ashton A Shaffer; Christine E Haugen; Nadia M Chu; Deidra C Crews; Silas P Norman; Dorry L Segev; Mara A McAdams-DeMarco Journal: Clin J Am Soc Nephrol Date: 2020-05-07 Impact factor: 8.237
Authors: Margaux N Mustian; Vineeta Kumar; Katie Stegner; Darnell Mompoint-Williams; Michael Hanaway; Mark H Deierhoi; Carlton Young; Babak J Orandi; Douglas Anderson; Paul A MacLennan; Rhiannon D Reed; Brittany A Shelton; Devin Eckhoff; Jayme E Locke Journal: Ann Surg Date: 2019-10 Impact factor: 12.969
Authors: Fawaz Al Ammary; Alvin G Thomas; Allan B Massie; Abimereki D Muzaale; Ashton A Shaffer; Brittany Koons; Mohamud A Qadi; Deidra C Crews; Jacqueline Garonzik-Wang; Hai Fang; Daniel C Brennan; Krista L Lentine; Dorry L Segev; Macey L Henderson Journal: Am J Transplant Date: 2019-02-08 Impact factor: 8.086